Oncology
Proteo-genomics system identifies malignant antibody targets
Published in Medical Devices and Surgical Technology Week, August 1st, 2004
According to researchers in Massachusetts, "[i]dentification of antibody targets associated with malignant disease is indispensable to developing passive and active antibody-based therapeutics or diagnostic agents."
To facilitate this process, Y.Y. Huang and colleagues at Framingham-based Genzyme Corporation "developed a novel technique combining Western blotting, genetic profiling, and mass spectroscopy that allows for the rapid and unambiguous identification of such antigens in a high-throughput manner."
"Herein, we demonstrate this technique, designated Ab...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Anti-Infectives
Alkaline cleaner can inactive scrapie agent on medical devices - Biotechnology
Rapid triple-labeling method devised for developing cells - Critical Care Medicine
Laryngeal tube enables rapid and simple ventilation in heart attack patients - Dermatology
Pulsed-dye laser treatment of reticulohistiocytoma effective - Genomics and Genetics
ChIP microarrays can identify genes silenced in cancer - Acoustic Neuroma
Translabyrinthine microsurgery preserves facial nerve function - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
